Treatment of solitary brain metastasis. Resection followed by whole brain radiation therapy (WBRT) and a radiation boost to the metastatic site.

PubWeight™: 0.82‹?›

🔗 View Article (PMID 14991201)

Published in Strahlenther Onkol on March 01, 2004

Authors

Dirk Rades1, Annette Raabe, Amira Bajrovic, Winfried Alberti

Author Affiliations

1: Department of Radiotherapy and Radiooncology, University Hospital Hamburg-Eppendorf, Germany. Rades.Dirk@gmx.net

Articles by these authors

No effect of the transforming growth factor β1 promoter polymorphism C-509T on TGFB1 gene expression, protein secretion, or cellular radiosensitivity. Int J Radiat Oncol Biol Phys (2012) 2.06

Evaluation of five radiation schedules and prognostic factors for metastatic spinal cord compression. J Clin Oncol (2005) 1.77

Prognostic factors for local control and survival after radiotherapy of metastatic spinal cord compression. J Clin Oncol (2006) 1.76

Serious adverse effects of amifostine during radiotherapy in head and neck cancer patients. Radiother Oncol (2004) 1.74

Final results of a prospective study comparing the local control of short-course and long-course radiotherapy for metastatic spinal cord compression. Int J Radiat Oncol Biol Phys (2010) 1.68

Individual radiosensitivity measured with lymphocytes may predict the risk of acute reaction after radiotherapy. Int J Radiat Oncol Biol Phys (2008) 1.50

Increasing the rate of late toxicity by changing the score? A comparison of RTOG/EORTC and LENT/SOMA scores. Int J Radiat Oncol Biol Phys (2003) 1.18

Individual radiosensitivity measured with lymphocytes may be used to predict the risk of fibrosis after radiotherapy for breast cancer. Radiother Oncol (2003) 1.14

Long-term radiation sequelae after breast-conserving therapy in women with early-stage breast cancer: an observational study using the LENT-SOMA scoring system. Int J Radiat Oncol Biol Phys (2003) 1.11

Is there a life-long risk of brachial plexopathy after radiotherapy of supraclavicular lymph nodes in breast cancer patients? Radiother Oncol (2004) 1.09

Association of single nucleotide polymorphisms in ATM, GSTP1, SOD2, TGFB1, XPD and XRCC1 with clinical and cellular radiosensitivity. Radiother Oncol (2010) 1.08

Matched pair analysis comparing surgery followed by radiotherapy and radiotherapy alone for metastatic spinal cord compression. J Clin Oncol (2010) 1.06

Surgery followed by radiotherapy versus radiotherapy alone for metastatic spinal cord compression from unfavorable tumors. Int J Radiat Oncol Biol Phys (2011) 1.04

Validation and simplification of a score predicting survival in patients irradiated for metastatic spinal cord compression. Cancer (2010) 1.02

Therapy of meningeal melanocytomas. Cancer (2004) 1.01

The effect of amifostine or IMRT to preserve the parotid function after radiotherapy of the head and neck region measured by quantitative salivary gland scintigraphy. Radiother Oncol (2008) 0.97

Preliminary results of spinal cord compression recurrence evaluation (score-1) study comparing short-course versus long-course radiotherapy for local control of malignant epidural spinal cord compression. Int J Radiat Oncol Biol Phys (2008) 0.96

A prospective evaluation of two radiotherapy schedules with 10 versus 20 fractions for the treatment of metastatic spinal cord compression: final results of a multicenter study. Cancer (2004) 0.94

Indicators of late normal tissue response after radiotherapy for head and neck cancer: fibroblasts, lymphocytes, genetics, DNA repair, and chromosome aberrations. Radiother Oncol (2002) 0.92

Well-differentiated neurocytoma: what is the best available treatment? Neuro Oncol (2005) 0.91

Individual patient data meta-analysis shows no association between the SNP rs1800469 in TGFB and late radiotherapy toxicity. Radiother Oncol (2012) 0.91

Radiation-induced plexopathy and fibrosis. Is magnetic resonance imaging the adequate diagnostic tool? Strahlenther Onkol (2004) 0.90

Is there a dose-effect relationship for the treatment of symptomatic vertebral hemangioma? Int J Radiat Oncol Biol Phys (2003) 0.88

Bone marrow-derived progenitor cells do not contribute to podocyte turnover in the puromycin aminoglycoside and renal ablation models in rats. Am J Pathol (2011) 0.88

Radiochemotherapy versus surgery plus radio(chemo)therapy for stage T3/T4 larynx and hypopharynx cancer - results of a matched-pair analysis. Eur J Cancer (2011) 0.87

Prognostic factors for different outcomes in patients with metastatic spinal cord compression from cancer of unknown primary. BMC Cancer (2012) 0.86

Neutron therapy, prognostic factors and dedifferentiation of adenoid cystic carcinomas (ACC) of salivary glands. Anticancer Res (2005) 0.85

Experiences with a new high-dose-rate brachytherapy (HDR-BT) boost technique for T3b prostate cancer. Strahlenther Onkol (2007) 0.84

Association between SNPs in defined functional pathways and risk of early or late toxicity as well as individual radiosensitivity. Strahlenther Onkol (2014) 0.84

Metastatic spinal cord compression: a validated survival score for elderly patients. Strahlenther Onkol (2014) 0.83

Comparison of radiochemotherapy alone to surgery plus radio(chemo)therapy for non-metastatic stage III/IV squamous cell carcinoma of the head and neck: A matched-pair analysis. Strahlenther Onkol (2011) 0.83

[Treatment for central neurocytoma: a meta-analysis based on the data of 358 patients]. Strahlenther Onkol (2003) 0.82

Late effects and cosmetic results of conventional versus hypofractionated irradiation in breast-conserving therapy. Strahlenther Onkol (2005) 0.81

Effect of irradiation on the expression of DNA repair genes studied in human fibroblasts by real-time qPCR using three methods of reference gene validation. Radiat Environ Biophys (2013) 0.81

Radiotherapy for oligometastatic disease in patients with spinal cord compression (MSCC) from relatively radioresistant tumors. Strahlenther Onkol (2010) 0.80

A patient questionnaire for radiation-induced brachial plexopathy. Am J Clin Oncol (2004) 0.79

Role of radiotherapy in the treatment of motor dysfunction due to metastatic spinal cord compression: comparison of three different fractionation schedules. Int J Radiat Oncol Biol Phys (2002) 0.79

[Effectiveness and toxicity of reirradiation (Re-RT) for metastatic spinal cord compression (MSCC)]. Strahlenther Onkol (2005) 0.79

The potential role of G2- but not of G0-radiosensitivity for predisposition of prostate cancer. Radiother Oncol (2010) 0.78

Cosmesis from the patient's and the doctor's view. Int J Radiat Oncol Biol Phys (2003) 0.78

Epoetin alfa improves survival after chemoradiation for stage III esophageal cancer: final results of a prospective observational study. Int J Radiat Oncol Biol Phys (2006) 0.78

Evaluation of prognostic factors and two radiation techniques in patients treated with surgery followed by radio(chemo)therapy or definitive radio(chemo)therapy for locally advanced head-and-neck cancer. Strahlenther Onkol (2008) 0.78

Comparison of 1 x 8 Gy and 10 x 3 Gy for functional outcome in patients with metastatic spinal cord compression. Int J Radiat Oncol Biol Phys (2005) 0.77

Effectiveness and toxicity of single-fraction radiotherapy with 1 x 8 Gy for metastatic spinal cord compression. Radiother Oncol (2005) 0.77

Hyperfractionated-accelerated radiotherapy followed by radical surgery in locally advanced tumors of the oral cavity. Strahlenther Onkol (2006) 0.77

Dose escalation for metastatic spinal cord compression in patients with relatively radioresistant tumors. Int J Radiat Oncol Biol Phys (2010) 0.77

Results of three dimensional conformal radiotherapy and hormonal therapy for local recurrence after radical prostatectomy. Strahlenther Onkol (2005) 0.76

Is grading of breast fibrosis with mammography feasible? Strahlenther Onkol (2005) 0.75

In reply to Kapoor. Int J Radiat Oncol Biol Phys (2013) 0.75

A validated score estimating ambulatory status following radiotherapy of elderly patients for metastatic spinal cord compression. BMC Cancer (2014) 0.75

A New Scoring Tool to Assess Overall Survival in Patients With Intracerebral Metastases From Gynecological Cancers. Int J Gynecol Cancer (2017) 0.75

Influence of the hemoglobin solution HBOC-201 on tissue oxygenation in the rat R1H-tumor. Artif Cells Blood Substit Immobil Biotechnol (2005) 0.75

Radiotherapy after high-dose chemotherapy and peripheral blood stem cell support in high-risk breast cancer. Int J Radiat Oncol Biol Phys (2002) 0.75

High accuracy of virtual simulation with the laser system Dorado CT4. Strahlenther Onkol (2007) 0.75

Re-irradiation of spinal cord compression due to metastasis in elderly patients. Anticancer Res (2014) 0.75

Emergency localization of radioactive seeds lost during intracoronary brachytherapy. Catheter Cardiovasc Interv (2004) 0.75

Reducing the overall treatment time for radiotherapy of metastatic spinal cord compression (MSCC): 3-year results of a prospective observational multi-center study. J Neurooncol (2004) 0.75